Amniotic Fluid Lactate in Perterm Premature Rupture of Membranes

December 27, 2018 updated by: Radwa Rasheedy Ali, Ain Shams University

Amniotic Fluid Lactate in Predicting Latency in Perterm Premature Rupture of Membranes

AF lactate level could help in predicting the duration from ROM till delivery

Study Overview

Status

Unknown

Conditions

Rupture of Membranes; Premature

Intervention / Treatment

Diagnostic test: amniotic fluid lactate

Study Type

Interventional

Enrollment (Anticipated)

Phase

Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Egypt
- Abbassya
  - Cairo, Abbassya, Egypt, 11566
    - Recruiting
    - Ainshams University maternity hospital
    - Contact:
      
      Ahmed K Maklad, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 35 years (Adult)

Accepts Healthy Volunteers

Genders Eligible for Study

Female

Description

Inclusion Criteria:

women with PPROM
GA between 24 to 34 weeks

Exclusion Criteria:

chorioamnionitis
previous Preterm labor
abruptio placentae
UTI ,pyelonephritis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Primary Purpose: Diagnostic
Allocation: N/A
Interventional Model: Single Group Assignment
Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
latency period Time Frame: upto 48 hours	duration from ROM till the occurrence of active labor	upto 48 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ain Shams University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2018

Primary Completion (Anticipated)

January 1, 2019

Study Completion (Anticipated)

March 1, 2019

Study Registration Dates

First Submitted

December 26, 2018

First Submitted That Met QC Criteria

December 27, 2018

First Posted (Actual)

December 31, 2018

Study Record Updates

Last Update Posted (Actual)